Evidence map›Paper›PMID 28785533›Full record

ArticleAfrican journal of laboratory medicine2017

Rolling Out Xpert

Ishani Pathmanathan, Anand Date, William L Coggin, John Nkengasong, Amy S Piatek, Heather Alexander

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in African journal of laboratory medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Profiles of Volatile Biomarkers Detect Tuberculosis from Skin.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  2. Performance of XpertPublic health action · 2020
    Article
  3. Review
  4. Review
  5. Assessment of GeneXpert MTB/RIF Performance by Type and Level of Health-Care Facilities in Nigeria.Nigerian medical journal : journal of the Nigeria Medical Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ishani PathmanathanDivision of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, USA.
Anand DateDivision of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, USA.
William L CogginDivision of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, USA.
John NkengasongDivision of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, USA.
Amy S PiatekGlobal Health Bureau, United States Agency for International Development, Washington DC, USA.
Heather AlexanderDivision of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, USA.
Centers for Disease Control and Prevention · USUnited States Agency for International Development · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundTo eliminate preventable deaths, disease and suffering due to tuberculosis (TB), improved diagnostic capacity is critical. The Cepheid Xpert OPPORTUNITIES FOR SYSTEM STRENGTHENING: In this commentary we discuss needs and opportunities for systems strengthening to support widespread scale-up of Xpert

conclusionXpert

Identifiers

PMID28785533
PMCPMC5523912
OpenAlexW2599609134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.